herpes simplex thymidine kinase
Biologicalexperimental
Clinical trial activity
1 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jun 1, 2000 (NCT00005025)
Timeline
2000s
- Jan 1, 2000
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Human herpesvirus 3 deoxypyrimidine kinaseSupplementation
ORF36 supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- herpes simplex thymidine kinase
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00005025 | Phase 2 | Jun 1, 2000 | Iowa Methodist Medical Center |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Iowa Methodist Medical Center | Academic/Hospital | 1 | 1 | 1 | 2000 |
1 organizations
Page 1 / 1